Contextualising the Online Pharmaceutical Trade

  • Lisa Sugiura
Part of the Palgrave Studies in Cybercrime and Cybersecurity book series (PSCYBER)


This chapter explores the online pharmaceutical trade setting the background for the rest of the book and presents the research questions that drove the study. The chapter starts by considering how medicines came to be available to purchase online and why this is seen as problematic via the associated risks. A critical discussion is then presented, unpacking these risks and how the discourses surrounding them are intertwined with authoritative challenges. The chapter concludes with an empirical examination of the online pharmaceutical trade.


Online pharmacies Unauthorised medicines Counterfeit medicine Cybercrime Governance 


  1. Aldridge, J., & Décary-Hétu, D. (2014). Not an ‘Ebay for Drugs’: The Cryptomarket ‘Silk Road’ as a paradigm shifting criminal innovation.
  2. Armstrong, K., Schwartz, J. S., & Asch, D. A. (1999). Direct sale of sildenafil (Viagra) to consumers over the internet. The New England Journal of Medicine, 341(18), 1389–1392.CrossRefGoogle Scholar
  3. Arruñada, B. (2004). Quality safeguards and regulation of online pharmacies. Health Economics, 13(4), 329–344.CrossRefGoogle Scholar
  4. Attaran, A., Bate, R., & Kendall, M. (2011). Why and how to make an international crime of medicine counterfeiting. Journal of International Criminal Justice, 9(2), 325–354.Google Scholar
  5. Attaran, A., Barry, D., Basheer, S., Bate, R., Benton, D., Chauvin, J., & McKee, M. (2012). How to achieve international action on falsified and substandard medicines. BMJ, 345, e7381.CrossRefGoogle Scholar
  6. Baert, B., & De Spiegeleer, B. (2010). Quality analytics of internet pharmaceuticals. Analytical and Bioanalytical Chemistry, 398(1), 125–136.CrossRefGoogle Scholar
  7. Baker, L., Wagner, T. H., Singer, S., & Bundorf, M. K. (2003). Use of the internet and e-mail for health care information: Results from a national survey. JAMA, 289(18), 2400–2406.CrossRefGoogle Scholar
  8. Barratt, M. J. (2012). Silk Road: eBay for drugs. Addiction, 107(3), 683–683.CrossRefGoogle Scholar
  9. Bart, Y., Shankar, V., Sultan, F., & Urban, G. L. (2005). Are the drivers and role of online trust the same for all web sites and consumers? A large-scale exploratory empirical study. Journal of Marketing, 69(4), 133–152.CrossRefGoogle Scholar
  10. Bartlett, J. (2014). The dark net. London: Random House.Google Scholar
  11. Bate, R. (2012). Phake: The deadly world of falsified and substandard medicines. Washington, DC: AEI Press.Google Scholar
  12. Bate, R., & Attaran, A. (2010). A counterfeit drug treaty: Great idea, wrong implementation. The Lancet, 376(9751), 1446–1448.CrossRefGoogle Scholar
  13. Becker, H. (1963). Outsiders: Studies in the sociology of deviance. New York: The Free Press.Google Scholar
  14. Bertrand, M., & Mullainathan, S. (2001). Do people mean what they say? Implications for subjective survey data. American Economic Review, 91, 67–72.CrossRefGoogle Scholar
  15. Binns, R., & Driscoll, B. (2001). The internet, pharmaceuticals and the law. Drug Discovery Today, 6(9), 452–453.CrossRefGoogle Scholar
  16. Blenkinsopp, A., & Bradley, C. (1996). Patients, society, and the increase in self medication. BMJ: British Medical Journal, 312(7031), 629.CrossRefGoogle Scholar
  17. Bloom, B. S., & Iannacone, R. C. (1999). Internet availability of prescription pharmaceuticals to the public. Annals of Internal Medicine, 131(11), 830–833.CrossRefGoogle Scholar
  18. Bloom, B. S., & Iannacone, R. C. (2006). Changing availability and cost of internet physician consultations and prescription medications. Medical Informatics and the Internet in Medicine, 31(4), 247–253.CrossRefGoogle Scholar
  19. Bostwick, J. M., & Lineberry, T. W. (2007). Do cheap internet drugs threaten the safety of the doctor–patient relationship? Expert Opinion on Drug Safety, 6(1), 9–13.Google Scholar
  20. Brandt, S. D., Sumnall, H. R., Measham, F., & Cole, J. (2010). Analyses of second-generation ‘legal highs’ in the UK: Initial findings. Drug Testing and Analysis, 2(8), 377–382.CrossRefGoogle Scholar
  21. Briggs, D., & Baker, S. A. (2012). From the criminal crowd to the “mediated crowd”: The impact of social media on the 2011 English riots. Safer Communities, 11(1), 40–49.CrossRefGoogle Scholar
  22. Cahoy, D. R. (2007). Addressing the North-South divide in pharmaceutical counterfeiting. Wake Forest Intellectual Property Law Journal, 8(3), 407–432.Google Scholar
  23. Childress, J. F. (1982). Who should decide?: Paternalism in health care. New York: Oxford University Press.Google Scholar
  24. Cicero, T. J., Shores, C. N., Paradis, A. G., & Ellis, M. S. (2008). Source of drugs for prescription opioid analgesic abusers: A role for the internet? Pain Medicine, 9(6), 718–723.CrossRefGoogle Scholar
  25. Clark, E. (2008). Counterfeit medicines: The pills that kill.
  26. Cohen, R. A., & Stussman, B. (2010). Health information technology use among men and women aged 18–64: Early release of estimates from the National Health Interview Survey, January–June 2009. National Centre for Health Statistics.Google Scholar
  27. Cordaro, F. G., Lombardo, S., & Cosentino, M. (2011). Selling androgenic anabolic steroids by the pound: Identification and analysis of popular websites on the internet. Scandinavian Journal of Medicine & Science in Sports, 21(6), e247–e259.CrossRefGoogle Scholar
  28. Crocco, A. G., Villasis-Keever, M., & Jadad, A. R. (2002). Analysis of cases of harm associated with use of health information on the internet. JAMA, 287(21), 2869–2871.CrossRefGoogle Scholar
  29. David, M. (2010). Peer to peer and the music industry: The criminalization of sharing. London: Sage.Google Scholar
  30. Davies, S., Wood, D. M., Smith, G., Button, J., Ramsey, J., Archer, R., et al. (2010). Purchasing ‘legal highs’ on the internet—Is there consistency in what you get? QJM.
  31. Dondorp, A. M., Newton, P. N., Mayxay, M., Van Damme, W., Smithuis, F. M., Yeung, S., & White, N. J. (2004). Fake antimalarials in Southeast Asia are a major impediment to malaria control: Multinational cross-sectional survey on the prevalence of fake antimalarials. Tropical Medicine & International Health, 9(12), 1241–1246.CrossRefGoogle Scholar
  32. Easton, G. (2007). Clicking for pills. BMJ, 334(7583), 14–15.CrossRefGoogle Scholar
  33. EMCDDA. (2015). Trendspotter study ‘the internet and drug markets’.
  34. Eysenbach, G. (1999). Online prescribing of sildanefil (Viagra) on the World Wide Web. Journal of Medical Internet Research, 1(2), E10.CrossRefGoogle Scholar
  35. Eysenbach, G. (2001). What is e-health? Journal of Medical Internet Research, 3(2), e20.Google Scholar
  36. Fakeshare. (2015, February 24). Challenges for national competent authorities on the sale of medicinal products over the internet. Proceedings of the Fakeshare International Conference, Madrid.
  37. Fawcett, A. J. (2003). The international adult literacy survey in Britain: Impact on policy and practice. Dyslexia, 9(2), 99–121.CrossRefGoogle Scholar
  38. FDA Consumer Magazine. (2000). Buying drugs online: It’s convenient and private but beware of ‘rogue sites’.
  39. Finley, L. (2009). Online pharmaceutical sales and the challenge for law enforcement. In Crimes of the internet (pp. 101–128). Saddle River: Prentice Hall.Google Scholar
  40. Fittler, A., Lankó, E., Brachmann, B., & Botz, L. (2013). Behaviour analysis of patients who purchase medicines on the internet: Can hospital pharmacists facilitate online medication safety? European Journal of Hospital Pharmacy: Science and Practice, 20(1), 8–12.CrossRefGoogle Scholar
  41. Forman, R. F., & Block, L. G. (2006). The marketing of opioid medications without prescription over the internet. Journal of Public Policy Marketing, 25(2), 133–146.CrossRefGoogle Scholar
  42. Forman, R. F., Woody, G. E., McLellan, T., & Lynch, K. G. (2006). The availability of web sites offering to sell opioid medications without prescriptions. The American Journal of Psychiatry, 163(7), 1233–1238.CrossRefGoogle Scholar
  43. Forman, R. F., Marlowe, D. B., & McLellan, A. T. (2006). The internet as a source of drugs of abuse. Current Psychiatry Reports, 8(5), 377–382.CrossRefGoogle Scholar
  44. Fox, S. (2004). Older Americans and the internet. Washington, DC: Pew Internet & American Life Project.Google Scholar
  45. Fuchs, C. (2012). Social media, riots, and revolutions. Capital & Class, 36(3), 383–391.CrossRefGoogle Scholar
  46. Fung, C. H., Woo, H. E., & Asch, S. M. (2004). Controversies and legal issues of prescribing and dispensing medications using the internet. Mayo Clinic Proceedings, 79(2., Elsevier), 188–194.CrossRefGoogle Scholar
  47. Gallagher, J. C., & Colaizzi, J. L. (2000). Issues in internet pharmacy practice. Annals of Pharmacotherapy, 34(12), 1483–1485.CrossRefGoogle Scholar
  48. George, C. (2006a). Online healthcare: Internet pharmacies may not always be good for your health. In IFIP International Conference on Landscapes of ICT and Social Accountability (pp. 133–151), Turku, Finland, 27–29 Jun 2005.Google Scholar
  49. George, C. E. (2006b). Internet pharmacies: Global threat requires a global approach to regulation. Hertfordshire Law Journal, 4(1), 12–25.Google Scholar
  50. George, C. (2012). The internet and pharmaceutical drugs in the era of interoperable eHealth systems across the European Union. In eHealth: Legal, ethical and governance challenges (pp. 135–164). Berlin/Heidelberg: Springer.Google Scholar
  51. Gernburd, P., & Jadad, A. R. (2007). Will spam overwhelm our defenses? Evaluating offerings for drugs and natural health products. PLoS Medicine, 4(9), e274.CrossRefGoogle Scholar
  52. Ghodse, H. (2010). Watching internet pharmacies. The British Journal of Psychiatry, 196(3), 169–170.CrossRefGoogle Scholar
  53. Gordon, S., Forman, R. F., & Siatkowski, C. (2006). Knowledge and use of the internet as a source of controlled substances. Journal of Substance Abuse Treatment, 30(3), 271–274.CrossRefGoogle Scholar
  54. Grabosky, P. (2007). The internet, technology, and organized crime. Asian Journal of Criminology, 2(2), 145–161.CrossRefGoogle Scholar
  55. Graham, G. (1991). Criminalisation and control. In Policing and prescribing (pp. 245–260). London: Palgrave Macmillan.Google Scholar
  56. Gurau, C. (2005). Pharmaceutical marketing on the internet. Journal of Consumer Marketing, 22(7), 421–428.CrossRefGoogle Scholar
  57. Hall, A., & Antonopoulos, G. A. (2016). Fake meds online: The internet and the transnational market in illicit pharmaceuticals. London: Palgrave Macmillan.Google Scholar
  58. Hanif, M., Mobarak, M., Ronan, A., Rahman, D., Donovan, J., et al. (1995). Fatal renal failure caused by diethylene glycol in paracetamol exlixir: The Bangladesh epidemic. British Medical Journal, 311, 88–91.CrossRefGoogle Scholar
  59. Hardey, M. (2001). ‘E-health’: The internet and the transformation of patients into consumers and producers of health knowledge. Information, Communication & Society, 4(3), 388–405.CrossRefGoogle Scholar
  60. Harocopos, A., & Hough, M. (2011). Drug dealing in open-air markets. Problem-oriented guides for police problem-specific guides series. Guide No. 31.Google Scholar
  61. Harris, J., Stevens, P., & Morris, J. (2009). Keeping it real: Combating the spread of fake drugs in poor countries. London: International Policy Network.Google Scholar
  62. Henney, J. E. (2001). Cyberpharmacies and the role of the US Food and Drug Administration. Journal of Medical Internet Research, 3(1), e3.Google Scholar
  63. Hillebrand, J., Olszewski, D., & Sedefov, R. (2010). Legal highs on the internet. Substance Use & Misuse, 45(3), 330–340.CrossRefGoogle Scholar
  64. Holt, T. J. (2012). Examining the forces shaping cybercrime markets online. Social Science Computer Review, 31(2), 165–177.CrossRefGoogle Scholar
  65. Humble, C. (2005, August 21). Inside the fake Viagra factory. Sunday Telegraph.
  66. IMPACT [International Medical Products Anti-Counterfeiting Taskforce]. (2008). Counterfeit drugs kill! Geneva: World Health Organization.
  67. Interpol. (2012). Pharmaceutical crime. Fact sheet. Lyon: Interpol.
  68. IRACM [Institute of Research Against Counterfeit Medicines]. (2012). When fake medicines fund international terrorism and destabilize the global economy. Paris: Institute of Research Against Counterfeit Medicines.
  69. Jackson, G. (2009). Faking it: the dangers of counterfeit medicine on the internet. International Journal of Clinical Practice, 63(2), 181–181.Google Scholar
  70. Jackson, G., Arver, S., Banks, I., & Stecher, V. J. (2010). Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks. International Journal of Clinical Practice, 64(4), 497–504.CrossRefGoogle Scholar
  71. Jackson, G., Patel, S., & Khan, S. (2012). Assessing the problem of counterfeit medications in the United Kingdom. International Journal of Clinical Practice, 66(3), 241–250.CrossRefGoogle Scholar
  72. Jewkes, Y. (Ed.). (2013). Crime online. Oxon: Routledge.Google Scholar
  73. Kahan, S. E., Seftel, A. D., & Resnick, M. I. (2000). Sildenafil and the internet. The Journal of Urology, 163(3), 919–923.CrossRefGoogle Scholar
  74. Kao, S. L., Chan, C. L., Tan, B., Lim, C. T., Dalan, R., Gardner, D., & Lee, K. O. (2009). An unusual outbreak of hypoglycemia. New England Journal of Medicine, 360(7), 734–736.CrossRefGoogle Scholar
  75. Kennedy, V. (2011, March 9). Consumer health: Internet drug scams can make you sick. Wall Street Journal.
  76. Lapidus, M., & Dryankova-Bond, I. (2014). Free drug information resources on the internet. Journal of Consumer Health On the Internet, 18(4), 367–376.CrossRefGoogle Scholar
  77. Lavorgna, A. (2014). The online trade in counterfeit pharmaceuticals: New criminal opportunities, trends and challenges. European Journal of Criminology.
  78. Lavorgna, A. (2015). Organised crime goes online: Realities and challenges. Journal of Money Laundering Control, 18(2), 153–168.CrossRefGoogle Scholar
  79. Lewis, J. A. (2003). Cybersecurity: Turning national solutions into international cooperation. Washington, DC: Centre for Strategic & International Studies.Google Scholar
  80. Lexchin, J. (2012). Models for financing the regulation of pharmaceutical promotion. Globalization and Health, 8, 24.CrossRefGoogle Scholar
  81. Liang, B. A., & Mackey, T. (2009). Searching for safety: Addressing search engine, website, and provider accountability for illicit online drug sales. American Journal of Law and Medicine, 35(1), 125–184.Google Scholar
  82. Littlejohn, C., Baldacchino, A., Schifano, F., & Deluca, P. (2005). Internet pharmacies and online prescription drug sales: A cross-sectional study. Drugs: Education, Prevention, and Policy, 12(1), 75–80.Google Scholar
  83. Lupton, D. (1997). Consumerism, reflexivity and the medical encounter. Social Science & Medicine, 45(3), 373–381.CrossRefGoogle Scholar
  84. Lupton, D. (2003). The body. In The handbook of social studies in health and medicine (p. 50). London: Sage.Google Scholar
  85. Mackey, T. K. (2013). Global health diplomacy and the governance of counterfeit medicines: A mapping exercise of institutional approaches. Journal of Health Diplomacy, 1, 1–20.Google Scholar
  86. Mackey, T. K., & Liang, B. A. (2011). The global counterfeit drug trade: Patient safety and public health risks. Journal of Pharmaceutical Sciences, 100(11), 4571–4579.CrossRefGoogle Scholar
  87. Mackey, T. K., & Liang, B. A. (2013). Pharmaceutical digital marketing and governance: Illicit actors and challenges to global patient safety and public health. Globalization and Health, 9(1), 45.CrossRefGoogle Scholar
  88. Manchikanti, L. (2006). Prescription drug abuse: What is being done to address this new drug epidemic? Testimony before the subcommittee on criminal justice, drug policy and human resources. Pain Physician, 9(4), 287.Google Scholar
  89. MarkMonitor. (2009). MarkMonitor finds online drug brand abuse is growing.
  90. McCoy, D., Dharmdasani, H., Kreibich, C., Voelker, G. M., & Savage, S. (2012, October). Priceless: The role of payments in abuse-advertised goods. Proceedings of the 2012 ACM conference on Computer and Communications Security, ACM, pp. 845–856.Google Scholar
  91. McGauran, A. (2010). Online sale of drugs and tests should be better regulated, says Nuffield report. BMJ, 341, c5710.CrossRefGoogle Scholar
  92. Measham, F., Moore, K., Newcombe, R., & Zoë Welch (née Smith). (2010). Tweaking, bombing, dabbing and stockpiling: The emergence of mephedrone and the perversity of prohibition. Drugs and Alcohol Today, 10(1), 14–21.CrossRefGoogle Scholar
  93. Memmel, L. M., Miller, L., & Gardner, J. (2006). Over-the-internet availability of hormonal contraceptives regardless of risk factors. Contraception, 73(4), 372–375.CrossRefGoogle Scholar
  94. Moberly, T. (2007). Why the UK must continue to nurture skills required for drug development. The Pharmaceutical Journal, 279(7478), 557.Google Scholar
  95. Montoya, I. D., & Jano, E. (2007). Online pharmacies: Safety and regulatory considerations. International Journal of Health Services, 37(2), 279–289.CrossRefGoogle Scholar
  96. National Centre on Addiction and Substance Abuse (NCASA) at Columbia University (CASA Columbia). (2010). National survey of American attitudes on substance aebuse XV: Teens and parents.
  97. Newton, P. N., Green, M. D., Fernández, F. M., Day, N. P., & White, N. J. (2006). Counterfeit anti-infective drugs. The Lancet Infectious Diseases, 6(9), 602–613.CrossRefGoogle Scholar
  98. Nordt, S. P., Minns, A., Tomaszewski, C., Cantrell, F. L., & Clark, R. F. (2010). Retrospective review of digoxin exposures to a poison control system following recall of Digitek® tablets. American Journal of Cardiovascular Drugs, 10(4), 261–263.CrossRefGoogle Scholar
  99. Norris, P. (2001). Digital divide: Civic engagement, information poverty, and the internet worldwide. Cambridge: Cambridge University Press.CrossRefGoogle Scholar
  100. Office for National Statistics. (2014). Internet access – Households and individuals 2014. Accessed 7 Aug 2015.
  101. Okie, S. (2009). Multinational medicines―Ensuring drug quality in an era of global manufacturing. The New England Journal of Medicine, 361(8), 737–740.CrossRefGoogle Scholar
  102. Orizio, G., & Gelatti, U. (2010). Public e-health and new scenarios in terms of risks and opportunities: A specific focus on cyberpharmacies. Social Semiotics, 20(1), 29–41.CrossRefGoogle Scholar
  103. Orizio, G., Rubinelli, S., Schulz, P. J., Domenighini, S., Bressanelli, M., Caimi, L., & Gelatti, U. (2010). ‘Save 30% if you buy today’. Online pharmacies and the enhancement of peripheral thinking in consumers. Pharmacoepidemiology and Drug Safety, 19(9), 970–976.CrossRefGoogle Scholar
  104. Orizio, G., Merla, A., Schulz, P. J., & Gelatti, U. (2011). Quality of online pharmacies and websites selling prescription drugs: A systematic review. Journal of Medical Internet Research, 13(3), e74.CrossRefGoogle Scholar
  105. Palmer, H., & Conaty, P. (2002). Profiting from poverty: Why debt is big business in Britain. London: New Economics Foundation.Google Scholar
  106. Parker, H. J., Aldridge, J., & Measham, F. (1998). Illegal leisure: The normalization of adolescent recreational drug use. New York: Psychology Press.Google Scholar
  107. Pearson, G., & Hobbs, D. (2001). Middle market drug distribution. London: Home Office Research/Development and Statistics Directorate.Google Scholar
  108. Pew Research Internet Project. (2012). The Internet and Health. Available at: [Accessed November 2013].
  109. Raine, C., Webb, D. J., & Maxwell, S. R. (2009). The availability of prescription-only analgesics purchased from the internet in the UK. British Journal of Clinical Pharmacology, 67(2), 250–254.CrossRefGoogle Scholar
  110. Riccardi, M., Dugato, M., & Polizzotti, M. (2014). The theft of medicines from Italian hospitals. Milan/Trento: Transcrime – Joint Research Centre on Transnational Crime.Google Scholar
  111. Satchwell, G. (2004). A sick business: Counterfeit medicines and organised crime. London: Stockholm Network.Google Scholar
  112. Schifano, F., Deluca, P., & Baldacchino, A. (2006). Online availability of dextropropoxyphene over time, 2003–2005. Cyberpsychology & Behavior, 9(4), 404–409.CrossRefGoogle Scholar
  113. Schifano, F., Leoni, M., Martinotti, G., Rawaf, S., & Rovetto, F. (2003). Importance of cyberspace for the assessment of the drug abuse market: Preliminary results from the Psychonaut 2002 project. CyberPsychology & Behavior, 6(4), 405–410.Google Scholar
  114. Schmidt, M. M., Sharma, A., Schifano, F., & Feinmann, C. (2011). “Legal highs” on the net—Evaluation of UK-based websites, products and product information. Forensic Science International, 206(1), 92–97.CrossRefGoogle Scholar
  115. Schneider, J. L. (2003). Hiding in plain sight: An exploration of the illegal (?) activities of a drugs newsgroup. The Howard Journal of Criminal Justice, 42(4), 374–389.CrossRefGoogle Scholar
  116. Schneider, J. L., & Sutton, M. (1999). Keystroke crime: Telling IT like IT is and the need for an internet criminal activity survey. In Focus on police research and development. London: Home Office.Google Scholar
  117. Shaw, J., & Baker, M. (2004). “Expert patient”—Dream or nightmare?: The concept of a well informed patient is welcome, but a new name is needed. BMJ: British Medical Journal, 328(7442), 723.CrossRefGoogle Scholar
  118. Smith, A. (1937). The wealth of nations [1776] (p. 421). na.Google Scholar
  119. Sugiura, L., Pope, C., & Webber, C. (2012, June). Buying unlicensed slimming drugs from the web: A virtual ethnography. Proceedings of the 4th annual ACM Web Science Conference, ACM, pp. 284–287.Google Scholar
  120. Taylor, I., Walton, P., & Young, J. (1973). The new criminology: For a social theory of deviance. London: Routledge.CrossRefGoogle Scholar
  121. Tonkin, E., Pfeiffer, H. D., & Tourte, G. (2012). Twitter, information sharing and the London riots? Bulletin of the American Society for Information Science and Technology, 38(2), 49–57.CrossRefGoogle Scholar
  122. Townsend, M. (2009). Health fears grow as fake drugs flood into Britain.
  123. Transcrime. (2010). FAKES – Fighting against brand counterfeiting in three key european member states. In Towards a more comprehensive strategy. Milan-Trento: Transcrime.
  124. Transcrime. (2012). Analysis of the draft protocol to eliminate illicit trade in tobacco products. Milan: Transcrime.
  125. Tuffs, A. (2002). Internet sales threaten drug companies’ supremacy. BMJ: British Medical Journal, 324(7344), 998.CrossRefGoogle Scholar
  126. Van Hout, M. C., & Bingham, T. (2013a). ‘Silk Road’, the virtual drug marketplace: A single case study of user experiences. International Journal of Drug Policy, 24(5), 385–391.CrossRefGoogle Scholar
  127. Van Hout, M. C., & Bingham, T. (2013b). ‘Surfing the Silk Road’: A study of users’ experiences. International Journal of Drug Policy, 24(6), 524–529.CrossRefGoogle Scholar
  128. Van Hout, M. C., & Bingham, T. (2014). Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. International Journal of Drug Policy, 25(2), 183–189.CrossRefGoogle Scholar
  129. Videau, J. Y., & Fundafunda, B. (2000). Generic drugs: The hidden issues of quality and cost. WHO Drug Information, 14(2), 77–81.Google Scholar
  130. Wagner, M. L., Alonso, J., & Mehlhorn, A. J. (2001). Comparison of internet and community pharmacies. Annals of Pharmacotherapy, 35(1), 116–119.CrossRefGoogle Scholar
  131. Wall, D. (2001). Maintaining order and law on the internet. In Crime and the internet (p. 167). London: Routledge.Google Scholar
  132. Wall, D. S. (2007). Cybercrime: The transformation of crime in the information age (Vol. 4). Cambridge: Polity.Google Scholar
  133. Wall, D. S., & Large, J. (2010). Jailhouse frocks: Locating the public interest in policing counterfeit luxury fashion goods. British Journal of Criminology.
  134. Weiss, A. M. (2006). Buying prescription drugs on the internet: Promises and pitfalls. Cleveland Clinic Journal of Medicine, 73(3), 282–288.CrossRefGoogle Scholar
  135. Welcome Trust. (2009, November 18). Experts outline major challenges in counterfeit medicine fight.
  136. World Health Organisation. (2009). International Medical Products Anti-Counterfeiting Taskforce — IMPACT.
  137. World Health Organisation. (2010a). ATLAS eHealth country profiles: Based on the findings of the second global survey on eHealth, Global observatory for eHealth series (Vol. 1). Geneva: World Health Organization.Google Scholar
  138. World Health Organisation. (2010b). Medicines: Counterfeit medicines. Fact sheet No. 275. Accessed Feb 2012.
  139. World Health Organization. (2011). Growing threat from counterfeit medicines. Bulletin of the World Health Organization, 88(4), 247.Google Scholar
  140. Yar, M. (2006). Cybercrime and society. London: Thousand Oaks.Google Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  • Lisa Sugiura
    • 1
  1. 1.University of PortsmouthPortsmouthUK

Personalised recommendations